Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
In Vivo (Athens, Greece)
|
April 30, 2024
Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model
Motokazu Sato, Kohei Mizuta, Qinghong Han, et al.
Anticancer Research
|
July 26, 2024
Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
October 30, 2024
Accurate and Safe Tumor Targeting of Orally-administered <i>Salmonella typhimurium</i> A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice
Sei Morinaga, Ming Zhao, Kohei Mizuta, et al.
Anticancer Research
|
February 29, 2024
Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts
Sei Morinaga, Qinghong Han, Yutaro Kubota, et al.
Anticancer Research
|
April 28, 2025
Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal Fibroblasts
Yohei Asano, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
May 31, 2024
DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts
Sei Morinaga, Qinghong Han, Yutaro Kubota, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)
Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Anticancer Research
|
October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
In Vivo (Athens, Greece)
|
April 30, 2024
Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model
Motokazu Sato, Kohei Mizuta, Qinghong Han, et al.
Anticancer Research
|
July 26, 2024
Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)
|
October 30, 2024
Accurate and Safe Tumor Targeting of Orally-administered <i>Salmonella typhimurium</i> A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice
Sei Morinaga, Ming Zhao, Kohei Mizuta, et al.
Anticancer Research
|
February 29, 2024
Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts
Sei Morinaga, Qinghong Han, Yutaro Kubota, et al.
Anticancer Research
|
April 28, 2025
Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal Fibroblasts
Yohei Asano, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research
|
May 31, 2024
DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts
Sei Morinaga, Qinghong Han, Yutaro Kubota, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)
Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Anticancer Research
|
October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Page
of 8